TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422G907. A total of 3 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,808,562 | +1390.4% | 202,300 | +2460.8% | 0.01% | – |
| Q2 2023 | $121,344 | -11.5% | 7,900 | +29.5% | 0.00% | – |
| Q1 2023 | $137,189 | -56.5% | 6,100 | -59.3% | 0.00% | -100.0% |
| Q4 2022 | $315,450 | -14.7% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $370,000 | -7.5% | 15,000 | -9.1% | 0.00% | 0.0% |
| Q2 2022 | $400,000 | -2.9% | 16,500 | +3.1% | 0.00% | – |
| Q1 2022 | $412,000 | +4.6% | 16,000 | +26.0% | 0.00% | – |
| Q4 2021 | $394,000 | +306.2% | 12,700 | +217.5% | 0.00% | – |
| Q3 2021 | $97,000 | +246.4% | 4,000 | +110.5% | 0.00% | – |
| Q2 2021 | $28,000 | +460.0% | 1,900 | +850.0% | 0.00% | – |
| Q1 2021 | $5,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 202,300 | $1,808,562 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 1,400 | $12,516 | 0.00% |
| SIMPLEX TRADING, LLC | 69,700 | $623 | 0.00% |
| JANE STREET GROUP, LLC | 57,200 | $511,368 | 0.00% |